Buy Right Impex Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 09-07-2024
- Paid Up Capital ₹ 16.41 Cr
as on 09-07-2024
- Company Age 41 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 776.57%
(FY 2023)
- Profit -34.71%
(FY 2023)
- Ebitda -81.80%
(FY 2023)
- Net Worth 502.60%
(FY 2023)
- Total Assets 326.49%
(FY 2023)
About Buy Right Impex
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 16.41 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Buy Right Impex Limited India are Neha Aggarwal as CFO and Sonam Nandwani as Company Secretary. Aarti, Ravi Birla, Pooja Suri, and One other member serve as directors at the Company.
- CIN/LLPIN
L22100DL1983PLC314401
- Company No.
314401
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Mar 1983
- Date of AGM
07 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Buy Right Impex?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sonam Nandwani | Company Secretary | 31-Mar-2021 | Current |
Neha Aggarwal | CFO | 03-Sep-2021 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjeev Jha | Director | 05-Feb-2021 | Current |
Aarti | Director | 25-Apr-2023 | Current |
Ravi Birla | Whole-Time Director | 26-May-2023 | Current |
Pooja Suri | Director | 31-Mar-2021 | Current |
Financial Performance and Corporate Structure Insights of Buy Right Impex.
Buy Right Impex Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 776.57% increase. The company also saw a substantial fall in profitability, with a 34.71% decrease in profit. The company's net worth Soared by an impressive increase of 502.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Buy Right Impex?
In 2023, Buy Right Impex had a promoter holding of 4.83% and a public holding of 95.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Buy Right Impex?
Unlock and access historical data on people associated with Buy Right Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Buy Right Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Buy Right Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.